# Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.

> **NCT04704531** · PHASE2 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 141 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Sodium Hyaluronate Ophthalmic 0.4% one drop twice a day (BID)
- **DRUG:** Sodium Hyaluronate Ophthalmic 0.4% one drop four times a day (QID)
- **DRUG:** Sodium Hyaluronate Ophthalmic 0.4% Six times per day

## Key facts

- **NCT ID:** NCT04704531
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-03
- **Primary completion:** 2022-06-08
- **Final completion:** 2022-06-08
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04704531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04704531, "Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04704531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*